Diabetes, Vol 48, Issue 10 1962-1970, Copyright © 1999 by American Diabetes Association

ARTICLES

Two novel immortal pancreatic beta-cell lines expressing and secreting human islet amyloid polypeptide do not spontaneously develop islet amyloid

S Andrikopoulos, CB Verchere, JC Teague, WM Howell, WY Fujimoto, TN Wight and SE Kahn
Department of Medicine, University of Washington, Seattle, USA.

Type 2 diabetes is characterized by islet amyloid deposits, which are primarily composed of the amyloidogenic human form of islet amyloid polypeptide (IAPP, amylin). The mechanism of islet amyloido-genesis is not known, but other products (e.g., apolipoprotein E and perlecan) contained within islet amyloid may be necessary. Because rodent IAPP does not form islet amyloid, the currently available beta-cell lines are not useful for studying processes involved in amyloid formation. To develop a suitable in vitro cell system for the study of islet amyloid formation, we generated two new beta-cell lines that express the amyloidogenic human IAPP. We did this by crossbreeding human IAPP transgenic mice with RIP-Tag mice that develop islet tumors and then culturing one of these islet tumors from two separate offspring of this cross. The resultant 2350-2C0 and 2511 cell lines produce human as well as mouse IAPP-like immunoreactivity (IAPP-LI) and immunoreactive insulin (IRI). Incubation of both these cell lines with 16.7 mmol/l glucose resulted in a two- to fourfold increase in human IAPP-LI, mouse IAPP-LI, and IRI secretion compared with 1.67 mmol/l glucose and the combination of 16.7 mmol/l glucose and 10 mmol/l arginine, 0.1 mmol/l 3-isobutyl-1-methylxanthine (IBMX), and 5 micromol/l carbachol induced a >50-fold increase in the release of these peptides. The omission of calcium from the above secretagogue cocktail reduced secretion of all three peptides to only two- to sixfold higher than the 16.7 mmol/l glucose condition. Perifusion with 16.7 mmol/l glucose plus 0.1 mmol/l IBMX caused a biphasic secretion of human IAPP-LI and mouse IAPP-LI, as well as IRI, in both cell lines, with the peak of the first phase being five- to sixfold higher than the prestimulated 1.67 mmol/l glucose condition. Immunoelectron microscopic inspection of both 2350-2C0 and 2511 cells after 7 days of culture did not reveal the presence of amyloid fibrils, suggesting the need for other critical components. We conclude that we have established two novel beta-cell lines that produce and secrete human IAPP in a regulated manner. These cell lines will be a useful tool to investigate the secretion of human IAPP as well as the necessity of other components for islet amyloid formation.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Kebede, J. Favaloro, J. E. Gunton, D. R. Laybutt, M. Shaw, N. Wong, B. C. Fam, K. Aston-Mourney, C. Rantzau, A. Zulli, et al. Fructose-1,6-Bisphosphatase Overexpression in Pancreatic {beta}-Cells Results in Reduced Insulin Secretion: A New Mechanism for Fat-Induced Impairment of {beta}-Cell Function Diabetes, July 1, 2008; 57(7): 1887 - 1895. [Abstract] [Full Text] [PDF]

				S. Andrikopoulos, R. L. Hull, C. B. Verchere, F. Wang, S. M. Wilbur, T. N. Wight, L. Marzban, and S. E. Kahn Extended life span is associated with insulin resistance in a transgenic mouse model of insulinoma secreting human islet amyloid polypeptide Am J Physiol Endocrinol Metab, March 1, 2004; 286(3): E418 - E424. [Abstract] [Full Text]

				F. Wang, R. L. Hull, J. Vidal, M. Cnop, and S. E. Kahn Islet Amyloid Develops Diffusely Throughout the Pancreas Before Becoming Severe and Replacing Endocrine Cells Diabetes, November 1, 2001; 50(11): 2514 - 2520. [Abstract] [Full Text] [PDF]

				B. Xue and M. B. Zemel Agouti Signaling Protein Stimulates Islet Amyloid Polypeptide (Amylin) Secretion in Pancreatic {beta}-Cells Experimental Biology and Medicine, June 1, 2001; 226(6): 565 - 569. [Abstract] [Full Text] [PDF]

				J. Wang, J. Xu, J. Finnerty, M. Furuta, D. F. Steiner, and C. B. Verchere The Prohormone Convertase Enzyme 2 (PC2) Is Essential for Processing Pro-Islet Amyloid Polypeptide at the NH2-Terminal Cleavage Site Diabetes, March 1, 2001; 50(3): 534 - 539. [Abstract] [Full Text]